{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:10:16Z","timestamp":1760735416968,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejca.2020.09.029","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T08:39:00Z","timestamp":1603442340000},"page":"147-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hepatic arterial infusion of chemotherapy as an option in a multimodal treatment of metastatic squamous cell carcinoma of the anus"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-1642","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Dall\u2019Armellina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Perret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Smolenschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-7551","authenticated-orcid":false,"given":"Antoine","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Malka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Boige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2020.09.029_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Canc J Clin"},{"issue":"4\u20136","key":"10.1016\/j.ejca.2020.09.029_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11864-009-0103-7","article-title":"Treatment options in metastatic squamous cell carcinoma of the anal canal","volume":"9","author":"Eng","year":"2008","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.029_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.029_bib4","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.029_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(18)30321-8","article-title":"Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.029_bib6","first-page":"861","article-title":"[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]","volume":"86","author":"Faivre","year":"1999","journal-title":"Bull Canc"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.029_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000361051","article-title":"Carboplatin and paclitaxel treatment is effective in advanced anal cancer","volume":"87","author":"Kim","year":"2014","journal-title":"Oncology"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.029_bib8","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1245\/s10434-007-9467-8","article-title":"Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis","volume":"14","author":"Pawlik","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2020.09.029_bib9","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.18632\/oncotarget.2563","article-title":"The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal","volume":"5","author":"Eng","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.029_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jso.25320","article-title":"Multimodality treatment of oligometastatic anal squamous cell carcinoma: a case series and literature review","volume":"119","author":"Sclafani","year":"2019","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.029_bib11","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.029_bib12","first-page":"31","article-title":"Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses","volume":"64","author":"Chen","year":"1980","journal-title":"Canc Treat Rep"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.029_bib13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"10","author":"Rougier","year":"1992","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2020.09.029_bib14","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","article-title":"Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer","volume":"23","author":"Ducreux","year":"2005","journal-title":"J Clin Oncol"},{"issue":"42","key":"10.1016\/j.ejca.2020.09.029_bib15","first-page":"1652","article-title":"Therapeutic strategy for postoperative liver metastasis from esophageal squamous cell carcinoma; clinical efficacy of and problem with hepatic arterial infusion chemotherapy","volume":"48","author":"Nakajima","year":"2001","journal-title":"Hepatogastroenterology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920310376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920310376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:30:11Z","timestamp":1760733011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920310376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"alternative-id":["S0959804920310376"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.029","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic arterial infusion of chemotherapy as an option in a multimodal treatment of metastatic squamous cell carcinoma of the anus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}